Research in Drug Development (RD3)

Pharmacognosy Bioanalysis and Drug Discovery


His research projects focus mainly on :

the analysis of posttranslational modifications (PTMs) of proteins by mass spectrometry. The targeted PTMs are the oxidative ones (oxidation of tryptophan, tyrosine, lysine, cysteine, …) in the context of chronic inflammation pathologies/oxidative stress like in atherosclerosis/cardiovascular disease. Another type of PTMs that he studies, is the glycosylation. Glycosylation is the most abundant modification of proteins, and in the context of therapeutic proteins, more than 60 % of the currently approved biotherapeutics are glycosylated. His research is also devoted to the development of analytical tools for the glycosylation characterization. He currently develops his research projects at the Analytical Platform of the Faculty of Pharmacy.



Cédric Delporte


Faculté de Pharmacie

Campus de la Plaine

ULB CP*, boulevard du Triomphe, 1050 Bruxelles


2013-2017: Postdoctoral fellow on FNRS grant in the Laboratory of Pharmaceutical Chemistry and Analytical Platform of the Faculty of Pharmacy (ULB, Belgium)

2012-2013: Postdoctoral fellow at NIBRT (National Institute for Bioprocessing Research and Training, Dublin, Ireland) in the group of Prof. P. RUDD (2012-2013)

2012: PhD in Pharmaceutical sciences "Study by a liquid chromatography/mass spectrometry system of the modifications of apolipolipoprotein B-100 induced by myeloperoxidase.", Faculty of Pharmacy (ULB, Belgium)

2008-2012: Research fellow of the FNRS (Belgium) and PhD student in the Laboratory of Pharmaceutical Chemistry (ULB, Belgium) (2008-2012)

2012: Pharmacist with “La Plus Grande Distinction” at the Faculty of Pharmacy, ULB, Belgium)(2012)